Advances in nucleic acid therapeutics are changing healthcare by delivering promising drugs that use new technologies and modes of action to treat disease. Several of these innovative medicines are being utilized to treat infectious diseases, protein and gene deficiencies, and many types of cancers. With increased efforts and resources being directed into this area, we are excited to support the early stages of what may be a groundbreaking revolution in medicine.


Solutions for therapeutics development

There are two classes of nucleic acid therapeutics: mRNA-based therapeutics or vaccines and synthetic oligonucleotide therapeutics. Learn more below about the products and technologies you’ll need as you make critical choices to successfully develop and manufacture these revolutionary therapeutics and vaccines.
 

mRNA based therapeutics and vaccines are produced biosynthetically using nucleotides, enzymes, and mRNA modification systems.

Synthetic oligonucleotide therapeutics are produced chemically using DNA or RNA phosphoramidites.

Contact us

 

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.

Stylesheet for Classic Wide Template adjustments